Approval of Drug Derived From Cannabis Not Necessarily a Win for Industry

Cannabis Business Times
Jul 20, 2018, 8:30 am39 pts
The Food and Drug Administration on June 25 approved for the first time a drug made from cannabidiol (CBD), a molecule derived from the cannabis plant. The drug, Epidiolex, was approved for the treatment of two types of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, that have been resistant to…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 73

Missouri Marijuana Microbusinesses Begin First Crop Harvests Amid Struggle To Succeed 58

Calif. regulator departs a market in turmoil 58

‘They’re lying’: deal to reopen government could doom hemp 48

Texas Officials Post Hemp Law ‘Checklist’ List To Help Businesses Comply With State Cannabis Rules 44

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.